BigHat Biosciences: Funding, Investors & Team (Sep 2026)
BigHat is a designer of an AI-directed protein helpful stage used to incorporate immunizer portrayal lab with AI innovations to design particles with additional perplexing capabilities and better biophysical properties. The organization is applying these plan abilities to foster new ages of more secure and more successful medicines for patients experiencing the present most testing sicknesses.
BigHat Biosciences has raised $94.0M across 2 funding rounds on record, the most recent a Series B of $75.0M announced in Jul 2022.
That round is above the $5.8M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
BigHat Biosciences Company Profile and Key Stats
Latest funding round on record: Jul 2022.
BigHat Biosciences Funding Rounds
BigHat Biosciences raised $19.0M in a Series A announced in Feb 2021.
1.4 years later, a Series B of $75.0M was announced in Jul 2022.
BigHat Biosciences Founders and Leadership Team
Contact details for the BigHat Biosciences team: 2 of 2 have an email address on file.
Start 14-day free trial →BigHat Biosciences Funding Compared to Other Artificial Intelligence Startups
BigHat Biosciences' latest round of $75.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BigHat Biosciences in Artificial Intelligence and San Mateo
Companies Similar to BigHat Biosciences
Positron provides hardware for implementing Transformer Model Inference in generative AI systems. The…
Clay creates automation tools that improve data quality and streamline outreach efforts for sales and…
WINT - Water Intelligence developing advanced solutions for smart water management and control. The company…
KingsCrowd is an online private market rating and analytics platform for equity crowdfunding research and…
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
BigHat Biosciences Funding FAQs
What does BigHat Biosciences do?
BigHat is a designer of an AI-directed protein helpful stage used to incorporate immunizer portrayal lab with AI innovations to design particles with additional perplexing capabilities and better biophysical properties. The organization is applying these plan abilities to foster new ages of more secure and more successful medicines for patients experiencing the present most testing sicknesses.
How much funding has BigHat Biosciences raised?
BigHat Biosciences has raised $94.0M across 2 rounds on record. The most recent is a Series B of $75.0M announced in Jul 2022.
When did BigHat Biosciences last raise funding?
BigHat Biosciences' most recent funding round on record is a Series B of $75.0M, announced in Jul 2022.
Who founded BigHat Biosciences?
FundedIQ lists Peyton Greenside (Founder) at BigHat Biosciences.
Who is the CEO of BigHat Biosciences?
Mark DePristo is listed as CEO at BigHat Biosciences.
Where is BigHat Biosciences headquartered?
BigHat Biosciences is based in San Mateo, California, United States.
How many employees does BigHat Biosciences have?
BigHat Biosciences is in the 11-50 employee band.
How does BigHat Biosciences' funding compare to other Artificial Intelligence startups?
BigHat Biosciences' latest round of $75.0M is above the $5.8M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's BigHat Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BigHat Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.